Carbamazepine for combativeness in acute traumatic brain injury



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Chatham-Showalter, P. E.
	Search for Related Content



	PubMed Citation
	Articles by Chatham-Showalter, P. E.

J Neuropsychiatry Clin Neurosci 1996; 8:96-99
Copyright © 1996 by American Neuropsychiatric Association

REGULAR ARTICLES

Carbamazepine for combativeness in acute traumatic brain injury

PE Chatham-Showalter
Department of Psychiatry, Lehigh Valley Hospital, Allentown, PA 18103, USA.

Psychiatrists increasingly consult on the treatment of acute traumatic brain injury (TBI) when combativeness compromises safe critical care. The author discusses use of carbamazepine for 7 combative patients with multiple trauma including TBI. This cohort had a clinical decrease in combativeness within 4 days after carbamazepine, compared with this Level I trauma center's experience of prolonged combative periods without its use.

This article has been cited by other articles:

E. Kim and T. J. Humaran
Divalproex in the Management of Neuropsychiatric Complications of Remote Acquired Brain Injury
J Neuropsychiatry Clin Neurosci, May 1, 2002; 14(2): 202 - 205.
[Abstract] [Full Text] [PDF]

P. E. Chatham Showalter and D. N. Kimmel
Agitated Symptom Response to Divalproex Following Acute Brain Injury
J Neuropsychiatry Clin Neurosci, August 1, 2000; 12(3): 395 - 397.
[Abstract] [Full Text]

Get information about faster international access.